J.-Matthias Graf von der Schulenburg
YOU?
Author Swipe
View article: Digital Transformation and the Implementation of Agile Work in the Financial Services Sector – A Multiple Case Study
Digital Transformation and the Implementation of Agile Work in the Financial Services Sector – A Multiple Case Study Open
Digital transformation poses challenges for incumbent financial services providers. Agile work methods are implemented as a possible response. Using Work System Theory as the underlying theoretical lens we conducted a holistic multiple cas…
View article: EPI-14-1149 from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study
EPI-14-1149 from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study Open
EPI-14-1149 . EGFR mutation type by tissue source tested
View article: Supplemental Table S3 from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study
Supplemental Table S3 from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study Open
Supplemental Table S3. Tissue source and testing method used for EGFR mutation analysis
View article: Data from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study
Data from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study Open
Introduction: EGFR mutations confer sensitivity to EGFR tyrosine kinase inhibitors (TKI) in advanced non–small cell lung cancer (NSCLC). We investigated the clinicopathologic characteristics associated with EGFR mutations and their impact …
View article: Supplemental Table S2 from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study
Supplemental Table S2 from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study Open
Supplemental Table S2. EGFR testing methods by tissue source tested
View article: EPI-14-1149 from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study
EPI-14-1149 from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study Open
EPI-14-1149 . EGFR mutation type by tissue source tested
View article: Supplemental Table S2 from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study
Supplemental Table S2 from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study Open
Supplemental Table S2. EGFR testing methods by tissue source tested
View article: Supplemental Table S3 from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study
Supplemental Table S3 from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study Open
Supplemental Table S3. Tissue source and testing method used for EGFR mutation analysis
View article: Data from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study
Data from <i>EGFR</i> Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study Open
Introduction: EGFR mutations confer sensitivity to EGFR tyrosine kinase inhibitors (TKI) in advanced non–small cell lung cancer (NSCLC). We investigated the clinicopathologic characteristics associated with EGFR mutations and their impact …
View article: The Influence of different Sources on Disease-related Knowledge among Patients with Rare Diseases: A Qualitative Study
The Influence of different Sources on Disease-related Knowledge among Patients with Rare Diseases: A Qualitative Study Open
Background: Finding reliable information on one of more than 7,000 rare diseases is a major challenge for those affected. Since rare diseases are defined only by the prevalence criterion, a multitude of heterogeneous diseases are included.…
View article: German Value Set for the EQ-5D-5L
German Value Set for the EQ-5D-5L Open
This study provided values for the health states of the German version of EQ-5D-5L representing the preferences of the German population. The study successfully employed for the first time worldwide the improved protocol 2.0. The value set…
View article: Therapy preferences of patients with lung and colon cancer: a discrete choice experiment
Therapy preferences of patients with lung and colon cancer: a discrete choice experiment Open
Objectives: There is increasing interest in studies that examine patient preferences to measure health-related outcomes. Understanding patients’ preferences can improve the treatment process and is particularly relevant for oncology. In th…
View article: Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysis
Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysis Open
BACKGROUND: Smoking is a major risk factor for chronic obstructive pulmonary disease (COPD). For current smokers who are diagnosed with COPD, their first treatment option is to stop smoking. Motivation is necessary for long-term smoking ce…
View article: Position Paper: Cornerstones for an ethically and legally informed practice of whole genome sequencing: code of conduct and patient consent models. (2nd edition)
Position Paper: Cornerstones for an ethically and legally informed practice of whole genome sequencing: code of conduct and patient consent models. (2nd edition) Open
Developed by scientists from different disciplines the position paper “Cornerstones for an ethically and legally informed practice of Whole Genome Sequencing” was published in a second, updated edition. The first edition published in 2013 …